Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Drugpatentwatch trametinib?Excipients list used in dexamethasone creams?How does iron rich food intake impact lipitor's efficacy?Somatuline depot patent expiry date?
See the DrugPatentWatch profile for Zioptan
Zioptan (tafluprost) is marketed as a glaucoma eye drop in a unit-dose form that is intended to be used without preservatives. That unit-dose packaging is designed to avoid the need for benzalkonium chloride (or other preservatives) in the bottle format [1].
Whether the medication is effectively preservative-free is tied to how it’s packaged. Zioptan is supplied in single-use unit doses, which is the mechanism used to keep preservatives out of the product you apply to the eye [1].
If a different product formulation is used (for example, a multi-dose bottle, a compounded version, or an alternative brand/generic), it may not have the same preservative-free design. For Zioptan specifically, the key detail is that the marketed product is provided in unit-dose form intended for preservative-free use [1].
Ask the prescriber or pharmacist to confirm: - you have the Zioptan unit-dose product (not a different tafluprost formulation), and - the exact strength and NDC/packaging match the preservative-free unit-dose version [1]. Sources: [1] https://www.drugpatentwatch.com/portfolio/zioptan/
Other Questions About Zioptan :